Share

    


Home / Search Results

Search Results

You searched for:

February 10, 2021
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
The Road to Recovery Report makes specific recommendations for maintaining the adaptations made necessary to accommodate the disruptions caused by the pandemic. Where possible, the report recommends building on that momentum to spur much-needed change in cancer care and research.
COVID-19 has highlighted how challenging it is for cancer care providers large and small when healthcare resources are limited. One oncologist shares her experience on a task force that drafted a series of recommendations for moving forward in cancer care as the pandemic recedes.
Assuming the ACCC presidency in March of 2020, just as the COVID-19 public health emergency went into effect, was certainly a dramatic way to enter office. That said, I am pleased with how much we have accomplished these last 12 months— despite the nationwide shutdown and ongoing pandemic.
At the risk of repeating a phrase that has been exhausted this year, the dawn of 2020 brought with it unprecedented times. Whereas a pandemic on its own would have dominated everything else, this year also brought on an economic depression; a racial awakening; record-breaking wildfires, hurricanes, and floods; political turmoil on an extraordinary scale; and a host of additional unique phenomena. …
While the pandemic continues to disrupt the conduct of cancer research, clinical trials remain crucial to advancing clinical care and providing the latest treatment options to all patients, including those in medically underserved communities. Given its location in the American southwest, Yuma Regional Medical Center (YRMC) Cancer Center has a long history of providing culturally appropriate care for …
We explore how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials.
Oncology Issues sat down with Dr. Schilsky to look back on his career and look forward to future research breakthroughs in this era of COVID-19 and beyond.
Lankenau Medical Center operationalized this joint ASCO-ACCC implicit bias aimed at ensuring patients with cancer in underrepresented groups have equitable access to care and clinical trials.
The Ohio State University Comprehensive Cancer Center developed the James Cancer Diagnostic Center, to deliver a comprehensive assessment of signs or symptoms of malignancy in a timely fashion.
Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
Highlights from the ACCC 50th Annual Meeting & Cancer Center Business Summit #AMCCBS.
Highlights from the ACCC 49th Annual Meeting and Cancer Center Business Summit.
ACCC and AstraZeneca were recognized for their joint effort in the Rural Appalachian Lung Cancer Screening Initiative at the Cancer Moonshot: Goals Forum hosted, by the President and First Lady.
This is the story of how a large independent practice in northwest Arkansas has nurtured its research program over several decades and is now able to offer patients access to phase I, II, and III trials close to home and their families.
Adopting a human-centered approach to designing clinical trials that considers the preferences and experiences of rural patients with cancer and providers could increase patient enrollment and close care gaps.
A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.